APPLICATION
ANDA081239
TYPE
ANDA
ORIGINAL APPROVAL
1992-10-30
LATEST ACTION
1997-11-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CYCRINDiscontinued
MEDROXYPROGESTERONE ACETATE 2.5MG · TABLET · ORAL
Approval history
1997-11-28Manufacturing (CMC) · Supplement 4AP
1995-10-23Manufacturing (CMC) · Supplement 3AP
1993-05-14Manufacturing (CMC) · Supplement 1AP
1992-10-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.